IP Library Granted Patent US 7,504,230
Granted Patent B2
US 7,504,230 · App. 10/714,163 · Granted Mar 17, 2009

Method of identifying a useful set of signal transduction proteins from a multiplicity of potentially useful proteins

Assignee: Trelolis Bioscience, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,504,230
App. No.
10/714,163
Granted
Mar 17, 2009
Kind
B2
Abstract

The present invention is a cell-based method of identifying a set of signal transduction proteins having an intracellular localization pattern responsive to toxic compounds. The method requires identifying and screening an initial set of signal transduction proteins against a set of toxic compounds, and determining changes in intracellular localization pattern of each of the proteins. Proteins whose changes in intracellular localization pattern are redundant are discarded from the initial set, and new proteins are added to provide a new set of proteins. I repeat the method steps with new sets of proteins until the set of proteins provides me at least 5 principal components with respect to the range of compounds marketed as small organic molecules.

Claims (12)

1. A method to identify a set of signal transduction proteins whose intracellular localization pattern changes in response to toxic compounds, which method comprises

identifying a first set of signal transduction proteins;

providing a set of toxic compounds;

contacting each signal transduction protein of the first set with each one of the toxic compounds;

determining the changes in intracellular localization pattern of each of the signal transduction proteins of said first set in response to each of the toxic compounds;

discarding those signal transduction proteins from said first set whose changes in intracellular localization pattern are redundant;

adding new signal transduction proteins to provide a second set of signal transduction proteins;

contacting each signal transduction protein of the second set with each of the toxic compounds;

determining the changes in the intracellular localization pattern of each of the signal transduction proteins of said second set in response to each of the toxic compounds;

discarding those signal transduction proteins from said second set whose changes in intracellular localization patterns are redundant;

adding new signal transduction proteins to provide a third set of signal transduction proteins; and

repeating the steps for which the second set of signal transduction proteins was used until a final set of proteins is identified which provides at least five principal components with respect to the range of compounds marketed as small organic molecules.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2012
From: TRELLIS BIOSCIENCE, INC.
To: TRELLIS BIOSCIENCE, LLC
Reel/Frame 028014/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2009
From: KAUVAR, LAWRENCE M.
To: TRELLIS BIOINFORMATICS, INC.
Reel/Frame 022198/0930 →
CHANGE OF NAME Recorded Feb 3, 2009
From: TRELLIS BIOINFORMATICS, INC.
To: TRELLIS BIOSCIENCE, INC.
Reel/Frame 022198/0953 →
Continuity (2)
Continuation In Part 0933261100 · Jun 14, 1999
Related Publication 20040161797A1 · Aug 19, 2004